$716 Million is the total value of TYBOURNE CAPITAL MANAGEMENT (HK) LTD's 41 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CANADIAN PACIFIC KANSAS CITY (CP US) | $73,978,348 | -7.9% | 994,199 | 0.0% | 10.34% | +19.1% | ||
BCYC | BICYCLE THERAPEUTICS LTD-ADR (BCYC US)sponsored ads | $25,751,764 | -21.3% | 1,281,820 | 0.0% | 3.60% | +1.8% | |
ACELYRIN INC (SLRN US) | $22,683,596 | -51.3% | 2,230,442 | 0.0% | 3.17% | -37.1% | ||
STNE | STONECO LTD-A (STNE US) | $20,394,884 | -16.2% | 1,911,423 | 0.0% | 2.85% | +8.3% | |
ZNTL | ZENTALIS PHARMACEUTICALS INC (ZNTL US) | $19,287,410 | -28.9% | 961,486 | 0.0% | 2.70% | -8.1% | |
LIANBIO-ADR (LIAN US)sponsored ads | $4,922,324 | -34.6% | 3,303,573 | 0.0% | 0.69% | -15.5% | ||
TSHA | TAYSHA GENE THERAPIES INC (TSHA US) | $4,740,000 | +378.1% | 1,500,000 | 0.0% | 0.66% | +518.7% | |
DASH | DOORDASH INC - A (DASH US)cl a | $1,830,512 | +4.0% | 23,034 | 0.0% | 0.26% | +34.7% | |
ON | ON SEMICONDUCTOR (ON US) | $1,438,681 | -1.7% | 15,478 | 0.0% | 0.20% | +27.2% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Zahedi Capital Management LP #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
AMAZON.COM INC (AMZN US) | 42 | Q3 2023 | 22.4% |
SALESFORCE COM INC | 19 | Q1 2020 | 28.5% |
MERCADOLIBRE INC (MELI US) | 18 | Q3 2023 | 15.1% |
BICYCLE THERAPEUTICS PLC | 18 | Q3 2023 | 3.7% |
NETFLIX INC | 17 | Q2 2020 | 20.6% |
ATLASSIAN CORP PLC-CLASS A (TEAM US) | 17 | Q2 2022 | 13.9% |
VISA INC-CLASS A SHARES (V US) | 16 | Q3 2023 | 9.1% |
TWILIO INC - A (TWLO US) | 15 | Q1 2023 | 14.2% |
SQUARE INC - A (SQ US) | 15 | Q3 2023 | 6.3% |
YELP INC | 14 | Q3 2016 | 17.8% |
View TYBOURNE CAPITAL MANAGEMENT (HK) LTD's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Zentalis Pharmaceuticals, Inc. | February 14, 2023 | 2,231,427 | 3.9% |
EXICURE, INC. | May 11, 2022 | 5,856,310 | 4.8% |
BICYCLE THERAPEUTICS plc | March 14, 2022 | 1,408,259 | 4.8% |
TPG Pace Beneficial Finance Corp.Sold out | January 03, 2022 | 0 | 0.0% |
Farfetch Ltd | February 16, 2021 | 5,354,942 | 1.8% |
BOSTON BEER CO INCSold out | February 14, 2018 | 0 | 0.0% |
Workday, Inc.Sold out | February 14, 2018 | 0 | 0.0% |
DUNKIN' BRANDS GROUP, INC.Sold out | February 14, 2017 | 0 | 0.0% |
On Deck Capital, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
YELP INCSold out | February 14, 2017 | 0 | 0.0% |
View TYBOURNE CAPITAL MANAGEMENT (HK) LTD's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13G | 2023-02-14 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
SC 13D/A | 2022-05-11 |
View TYBOURNE CAPITAL MANAGEMENT (HK) LTD's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.